Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

4.8K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.8K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

11.6K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
11.6K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

8.2K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

4.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.9K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

10.7K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.7K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

9.9K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Decision-analytic models in the economic evaluation of community health worker programmes globally: a systematic review.

BMJ global health·2026
Same author

ROS-Mediated Controllable Targeted Protein Degradation: Progress and Reflections.

Journal of medicinal chemistry·2026
Same author

Correction method for cloud temperature retrieval combining rotational Raman, vibrational Raman, and elastic scattering lidar channels.

Applied optics·2026
Same author

High-flow nasal cannula for acute respiratory failure: a bibliometric analysis of current trends and future directions.

Frontiers in medicine·2026
Same author

Development and validation of a predictive model for septic shock in maternal sepsis: a retrospective cohort study in a single referral center.

BMC pregnancy and childbirth·2026
Same author

Lamotrigine Ameliorates Epilepsy during Pregnancy in Rats by Inhibiting Astrocyte Activation via the NLRP3/TXNIP Pathway.

Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology·2026
Same journal

Digitoxin as a novel synergistic partner of cisplatin in triple-negative breast cancer (TNBC) cells.

Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine·2026
Same journal

Tumour markers and evidence-based pathology.

Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine·2026
Same journal

An integrated bioinformatics and multi-omics investigation of the sirtuin family to identify their prognostic importance in human cancers.

Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine·2025
Same journal

Osteopontin-c gene expression and subcellular localization in ovarian cancer cells: Implications for prognosis and therapeutic responses.

Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine·2025
Same journal

Asporin increases the extracellular matrix cross-links and inhibits the cancer cell migration.

Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine·2025
Same journal

External validation of a serum tumor marker algorithm for early prediction of no durable benefit to immunotherapy in metastastic non-small cell lung carcinoma.

Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine·2025
See all related articles

Related Experiment Video

Updated: Feb 27, 2026

Therapeutic Gene Delivery and Transfection in Human Pancreatic Cancer Cells using Epidermal Growth Factor Receptor-targeted Gelatin Nanoparticles
08:35

Therapeutic Gene Delivery and Transfection in Human Pancreatic Cancer Cells using Epidermal Growth Factor Receptor-targeted Gelatin Nanoparticles

Published on: January 4, 2012

28.8K

Transgelin-2: A potential oncogenic factor.

Ti Meng1, Leichao Liu1, Ruifang Hao1

  • 1Department of Pharmacy, The First Affiliated Hospital of Medical College, Xi'an Jiaotong University, Xi'an, China.

Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|June 23, 2017
PubMed
Summary
This summary is machine-generated.

Transgelin-2, an actin-binding protein, is linked to cancer progression. Further research into its function and role in diseases like cancer is crucial for new therapeutic strategies.

Keywords:
TAGLN2Transgelin-2actin-binding proteinsbiological functioncancer development

More Related Videos

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
07:47

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Published on: September 15, 2023

2.3K
Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

14.6K

Related Experiment Videos

Last Updated: Feb 27, 2026

Therapeutic Gene Delivery and Transfection in Human Pancreatic Cancer Cells using Epidermal Growth Factor Receptor-targeted Gelatin Nanoparticles
08:35

Therapeutic Gene Delivery and Transfection in Human Pancreatic Cancer Cells using Epidermal Growth Factor Receptor-targeted Gelatin Nanoparticles

Published on: January 4, 2012

28.8K
Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
07:47

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Published on: September 15, 2023

2.3K
Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

14.6K

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Oncology

Background:

  • Transgelin-2 (TAGLN2) is an actin-binding protein found in various cell types.
  • TAGLN2 expression is altered across different cells and tissues.
  • Dysregulation of Transgelin-2 is implicated in disease progression, particularly in malignant tumors.

Purpose of the Study:

  • To review the fundamental characteristics and functions of Transgelin-2.
  • To explore the biological role of Transgelin-2 in diverse diseases.
  • To provide a theoretical foundation for future research on Transgelin-2 and cancer development.

Main Methods:

  • Literature review of existing studies on Transgelin-2.
  • Analysis of gene expression data related to TAGLN2.
  • Synthesis of information on Transgelin-2's involvement in pathological processes.

Main Results:

  • Transgelin-2 exhibits diverse cellular functions.
  • Altered Transgelin-2 expression is associated with cancer hallmarks like invasion and metastasis.
  • The precise mechanisms of Transgelin-2 action in disease remain largely unknown.

Conclusions:

  • Transgelin-2 is a significant protein with a potential role in various diseases, especially cancer.
  • Understanding Transgelin-2's function is essential for developing novel cancer therapies.
  • Further investigation is warranted to elucidate the molecular mechanisms of Transgelin-2 in disease pathogenesis.